SLRX

Companies
NASDAQ
Salarius Pharmaceuticals Inc.
Health Care
Price Chart
Overview

About SLRX

salarius is an oncology based biotechnology company developing targeted treatments for patients who need them the most.

Market Cap
$2.0M
Volume
34.0K
Avg. Volume
189.9K
P/E Ratio
-0.08562704
Dividend Yield
0.00%
Employees
8.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
1.13
Moderate Correlation
Volatility
High (1.00)
Relative to market
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for SLRX.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, SLRX shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$2.0M
Volume34.0K
P/E Ratio-0.09
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
March 22, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how SLRX fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025